First Ever ALS Breakthrough!
INCELL Pioneering the World’s First Effective Cell Therapy for ALS
For Immediate Release July 25, 2024
(San Antonio, Texas). ALS, or amyotrophic lateral sclerosis, is defined by the ALS Association (als.org) as a
progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. ALS symptoms vary
and patients may lose the ability to speak, eat, move and breathe. There is no cure. The Mayo Clinic reports
(mayoclinic.org) that no treatments can reverse ALS damage, but they may slow the progression of disease
symptoms or help prevent complications. INCELL is committed to tackling innovative ALS therapy.
